Press release - 23/01/2025 ERC Funding for „EmbryoNet-AI“ Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform for the automated evaluation of experiments – for example, in drug development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-embryonet-ai
Event - 13/02/2025 Webinar on the biotech hub Singapore & Malaysia Online, Webinar https://www.gesundheitsindustrie-bw.de/en/event/webinar-biotech-hub-singapore-und-malaysia
Press release - 20/01/2025 New approach to fighting cancer: energy trap for tumor cells Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice and humans depend on a key enzyme of glycolysis, Aldolase A. When it is switched off, glycolysis reverses from an energy-producing to an energy-consuming process. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-fighting-cancer-energy-trap-tumor-cells
Event - 08/04/2025 - 10/04/2025 DMEA 2025 - Connecting Digital Health Berlin, Germany , Messe https://www.gesundheitsindustrie-bw.de/en/event/dmea-2025-connecting-digital-health
Event - 17/03/2025 - 19/03/2025 Bio Europe Spring 2025 Milano, Italy, Messe https://www.gesundheitsindustrie-bw.de/en/event/bio-europe-spring-2025
Press release - 20/01/2025 PAMSARC: New study at the NCT Heidelberg links research and clinical action Young patients suffering from two aggressive sarcoma types can now participate in the innovative PAMSARC therapy study at the NCT Heidelberg. The study uses molecular biological methods and tests the extent to which a new drug can improve the poor prognosis for these tumours.https://www.gesundheitsindustrie-bw.de/en/article/press-release/pamsarc-new-study-nct-heidelberg-links-research-and-clinical-action
Press release - 17/01/2025 The Minister President of Baden Wuerttemberg, Winfried Kretschmann, honors cutting-edge research at the Max Planck Institutes in Tübingen Winfried Kretschmann, the Minister President of Baden-Württemberg, Germany, visited the Max Planck Institutes for Biology Tübingen and Biological Cybernetics. During his tour, he commended the outstanding basic research in the natural sciences. He was particularly impressed by the innovative research projects spanning developmental and evolutionary biology, as well as neuroscience.https://www.gesundheitsindustrie-bw.de/en/article/press-release/minister-president-baden-wuerttemberg-winfried-kretschmann-honors-cutting-edge-research-max-planck-institutes-tubingen